Summary
IDEXX Laboratories, Inc. (IDXX) filed an 8-K on February 1, 2018, to announce its financial results for the fourth quarter and full year ended December 31, 2017. The report primarily serves to furnish the accompanying press release, which contains the detailed financial performance for the period. Investors should refer to the press release (Exhibit 99.1) for specific figures related to revenue, earnings, and other key financial metrics. This filing is a standard procedural step to disclose material financial information. While the 8-K itself is brief and points to the press release for substantive details, it confirms the company's adherence to reporting obligations. The disclosed results for 2017 and the fourth quarter would have been a key focus for investors assessing the company's operational success and financial health at that time, including trends in its various business segments.
Key Highlights
- 1IDEXX Laboratories announced its Q4 and Full Year 2017 financial results on February 1, 2018.
- 2The 8-K filing primarily furnishes a press release containing the detailed financial results.
- 3The press release (Exhibit 99.1) is the primary source of detailed financial information for investors.
- 4The filing confirms that the reported results are for the period ending December 31, 2017.
- 5The company's Chief Financial Officer and Treasurer, Brian P. McKeon, signed the report.
- 6This report is furnished under Item 2.02 and is not deemed 'filed' for purposes of Section 18 of the Exchange Act.